Trial intelligence / Profile preview

Human Microbiome and Healthcare Associated Infections in Older Veterans

NCT04218799Phase 4Completed

Sponsor
University of Maryland, Baltimore
Start
Aug 2014
Primary completion
Sep 2015
Modality
Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mupirocin, chlorhexidine + cymenol gel in Healthcare-Associated Infections (HAI), sponsored by University of Maryland, Baltimore. Started Aug 2014; status: completed.

02

Drugs

mupirocinchlorhexidine + cymenol gel
03

Conditions

Healthcare-Associated Infections (HAI)

Beyond the preview

Go deeper on NCT04218799.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04218799.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call